Efficacy and safety of ruzasvir 60 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4 or 6 infection

Eric Lawitz, Fred Poordad, Leah J. Anderson, Michelle Vesay, Michelle M. Kelly, Hong Liu, Wei Gao, Doreen Fernsler, Ernest Asante-Appiah, Michael N. Robertson, George J. Hanna, Eliav Barr, Joan Butterton, Kris V. Kowdley, Tarek Hassanein, Amandeep Sahota, Stuart C. Gordon, Wendy W. Yeh

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint Dive into the research topics of 'Efficacy and safety of ruzasvir 60 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4 or 6 infection'. Together they form a unique fingerprint.

Medicine & Life Sciences